About ALSA Research
Thirty years of bringing tomorrow's medicine to the tri-state area.
Founded in Stamford in 1994, ALSA Research now runs Phase II–IV clinical trials at three dedicated clinics across New York and Connecticut — with a patient community of more than 13 million within reach.
1994
Founded
3
Dedicated clinics
500+
Trials completed
Our story
From one clinic in Stamford to a tri-state network.
1994
Stamford Therapeutics Consortium founded
Dr. Paul Dalgin and his wife Judy found STC in Stamford, Connecticut, building one of the region’s most experienced independent research clinics.
2001
Bridgeport clinic opens
New England Research Associates (NERA) opens in Bridgeport near three major teaching hospitals, extending trial access along the I-95 corridor.
2022
Two clinics unify as ALSA Research
STC and NERA come together under one name, one team — shared recruitment, centralized contracting, and unified quality systems.
2025
Manhattan clinic opens
A modern 4,200 sq ft facility minutes from Grand Central and Penn Station brings ALSA to the 11M+ people within a 15-mile radius of Midtown.
Today
500+ trials and counting
Phase II–IV trials across eight therapeutic areas, with a 35,000+ patient registry and enrollment performance sponsors return for.
What we believe
Three principles behind every study.
01
Patients first.
Every protocol decision starts with participant safety: board-certified investigators, GCP-trained staff, and independent IRB oversight on every study.
02
Data sponsors can trust.
eSource-native operations, data entry within 24 hours of every visit, and zero FDA 483s across our history.
03
Research that reflects our community.
Our catchment is one of the most diverse in the country, and our enrollment reflects it — because medicine works best when it’s studied in everyone it will serve.
Three clinics, one team
Each clinic is local. The team behind it is shared.
Each location runs its own studies but shares a single recruitment platform, a 35,000+ patient registry, and centralized contracting and regulatory — so sponsors get parallel startup across all three clinics when a study qualifies for it.
Manhattan
Opened 2025
A modern 4,200 sq ft facility near Grand Central and Penn Station, catering to one of the most diverse patient populations in the country, with a focus on multiple therapeutic areas including general medicine, infectious disease, and CNS.
Visit clinic →
Stamford
Founded 1994 · Formerly Stamford Therapeutics Consortium
Our founding clinic and a pioneering clinic in weight-loss research, with deep experience across infectious disease, musculoskeletal, and pain trials — plus partnerships with cardiology and multispecialty practices.
Visit clinic →
Bridgeport
Founded 2001 · Formerly New England Research Associates
Serving Connecticut’s largest city and enabling clinical-trial access for a highly diverse and underserved community, with specialty experience in endocrinology and weight-loss indications.
Visit clinic →
What we run
Phase II–IV trials across eight therapeutic areas.
By the numbers
30+
Years in research
500+
Trials completed
3
Dedicated clinics
35,000+
Patient registry
95%+
Subject retention
0
FDA 483s
Technology & quality
A technology-forward clinic network.
eSource from the start
We were early adopters of eSource and eRegulatory technology — source data is captured electronically at the point of care, not transcribed from paper afterward. Monitors get remote access; sponsors get cleaner data, faster.
AI-assisted quality oversight
We use proprietary AI-based systems internally to help drive quality and compliance across our operations — strengthening the oversight our teams provide on every study.
Centralized startup, parallel activation
One regulatory and contracting team serves all three clinics, turning submissions around in under a week — so a multi-site award activates in parallel instead of one clinic at a time.
Careers
Do work that changes medicine.
We hire across all three locations for clinical research coordinator, nursing, regulatory, and administrative roles.